Novartis AG
Utility Patent Applications
Last updated:
List of all Novartis AG patents 676 in total
| Status | Patent |
|---|---|
Application | Utility: Paediatric Compositions For Treating Multiple Sclerosis Filling date: 23 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: FORMULATIONS OF (S)-3-AMINO-6-METHOXY-N-(3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPYL)-5-(TRI- FLUOROMETHYL)PICOLINAMIDE Filling date: 23 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY Filling date: 23 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: METHODS FOR TREATING OCULAR DISEASES Filling date: 23 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) Filling date: 23 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: INTERMITTENT DOSING OF MDM2 INHIBITOR Filling date: 23 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES Filling date: 23 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: COMBINATION THERAPIES Filling date: 23 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: PHARMACEUTICAL COMBINATION COMPRISING LSZ102 AND ALPELISIB Filling date: 23 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide Derivatives Filling date: 23 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: USE OF an anti-P-selectin antibody Filling date: 23 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: CKIT ANTIBODY DRUG CONJUGATES Filling date: 23 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: 10-(DI(PHENYL)METHYL)-4-HYDROXY-8,9,9A,10-TETRAHYDRO-7H-PYRROLO[1 ',2':4,5]PYRAZINO[1,2-B]PYRIDAZINE-3,5-DIONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE ORTHOMYXOVIRUS REPLICATION FOR TREATING INFLUENZA Filling date: 23 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: INDOLE-2-CARBONYL COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HEPATITIS B Filling date: 23 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS Filling date: 23 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: OPTIMIZED LENTIVIRAL TRANSFER VECTORS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof Filling date: 23 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: CHIMERIC ANTIGEN RECEPTOR THERAPY IN COMBINATION WITH IL-15R AND IL15 Filling date: 23 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: NOVEL RAPAMYCIN DERIVATIVES Filling date: 23 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: Ribociclib Tablet Filling date: 23 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile Filling date: 23 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: Tetrahydro-Pyrido-Pyrimidine Derivatives Filling date: 23 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: NATRIURETIC PEPTIDE RECEPTOR 1 ANTIBODIES AND METHODS OF USE Filling date: 23 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE Filling date: 23 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE Filling date: 23 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: COMBINATION OF A MCL-1 INHIBITOR AND A STANDARD OF CARE TREATMENT FOR HEMATOLOGIC CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF Filling date: 23 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: LIQUID IL-1 BETA ANTIBODY FORMULATION HAVING PH OF 5.5 TO 7.0 Filling date: 23 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis Filling date: 23 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER Filling date: 23 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: POLYOMAVIRUS NEUTRALIZING ANTIBODIES Filling date: 23 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: Solid Forms Comprising An Oxime Ether Compound, Compositions and Methods of Use Thereof Filling date: 23 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS Filling date: 23 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC LOW DENSITY LIPOPROTEIN - RELATED PROTEIN 6 (LRP6) MULTIVALENT ANTIBODIES Filling date: 23 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY Filling date: 23 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: METHODS FOR TREATING HEMATOLOGIC CANCERS Filling date: 23 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: METHODS OF TREATING METABOLIC DISORDERS WITH FGF21 VARIANTS Filling date: 23 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: 1-PYRIDAZIN-/TRIAZIN-3-YL-PIPER(-AZINE)/IDINE/PYROLIDINE DERIVATIVES AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: USE OF IL-1BETA BINDING ANTIBODIES Filling date: 23 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: IMMUNE-ENHANCING RNAS FOR COMBINATION WITH CHIMERIC ANTIGEN RECEPTOR THERAPY Filling date: 23 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS Filling date: 23 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: CONTAINER ARRANGEMENT INCLUDING A WIRELESS COMMUNICATION DEVICE AND METHOD FOR OPERATING THE SAME Filling date: 23 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: NLRP3 INFLAMMASOME INHIBITORS Filling date: 23 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: NLRP3 INFLAMMASOME INHIBITORS Filling date: 23 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: CRYSTALLINE FORMS OF N-[4-(CHLORODIFLUOROMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL]-5-(- 1H-PYRAZOL-5-YL)PYRIDINE-3-CARBOXAMIDE Filling date: 23 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: CHEMICAL PROCESS Filling date: 23 Sep 2025 Issue date: 19 Nov 2020 |
Showing 300 to 350 of 676 patents.